Showing results (1611-1620 of 1,668) with videos related to

Sort By:
Pageof 167
Journal of Medicinal Chemistry|June 19, 2001
Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonistsD A Brooks, G J Etgen, C J Rito, et al.
AJNR. American Journal of Neuroradiology|March 17, 2023
Incidental Findings from 16,400 Brain MRI Examinations of Research VolunteersP A Rowley, M J Paukner, L B Eisenmenger, et al.
Heliyon|February 7, 2023
CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversityB Ffrench, E Kashdan, Y Huang, et al.
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
Scientific Reports|June 18, 2020
Genome Diversity and the Origin of the Arabian HorseElissa J Cosgrove, Raheleh Sadeghi, Florencia Schlamp, et al.
Medicine|September 1, 2017
Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasmsMing-Ming Xu, Shi Yin, Ali A Siddiqui, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Genes, Brain, and Behavior|May 5, 2012
Family-based genome-wide association study of frontal θ oscillations identifies potassium channel gene KCNJ6S J Kang, M Rangaswamy, N Manz, et al.
JAMA Neurology|March 10, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical TrialsJennifer A Zimmer, Paul Ardayfio, Hong Wang, et al.
Progress in Community Health Partnerships : Research, Education, and Action|April 6, 2026
Integrating Hyperlocal and Community-Engaged Approaches to Qualitative Research for COVID-19 Syndemic Response: GEORGIA CEAL Early FindingsClaudia E Ordóñez, Gaëlle Sabben, Marisa Boily, et al.
Pageof 167